FA
BIIB icon

Fortis Advisors’s Biogen BIIB Stock Holding History

Fortis Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-285
Closed -$70K – 224
2020
Q4 		$70K Hold
285
– – 0.06% 98
2020
Q3 		$81K Sell
285
-17
-6% -$4.74K 0.08% 83
2020
Q2 		$81K Sell
302
-779
-72% -$234K 0.08% 91
2020
Q1 		$342K Sell
1,081
-44
-4% -$13.4K 0.23% 48
2019
Q4 		$334K Hold
1,125
– – 0.2% 69
2019
Q3 		$262K Buy
+1,125
New +$262K 0.12% 83
2018
Q4 		– Sell
-78
Closed -$28K – 302
2018
Q3 		$28K Hold
78
– – 0.02% 233
2018
Q2 		$23K Buy
+78
New +$21.9K 0.01% 237

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fortis Advisors's BIIB Position: Q1 2021 in Review

Fortis Advisors sold out of Biogen (BIIB) in Q1 2021, closing a stake of 285 shares — an estimated $70K sold.

Fortis Advisors first reported a position in BIIB in Q2 2018 and held it in 8 quarters. The position peaked at $342K in Q1 2020. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Fortis Advisors reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Fortis Advisors sold 285 Biogen shares in Q1 2021, an estimated $70K.
  • Fortis Advisors first reported a position in Biogen in Q2 2018 and held it in 8 quarters.
  • Fortis Advisors's Biogen position peaked at $342K in Q1 2020.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Fortis Advisors's 13F filing for Q1 2021, filed 13 May 2021.